TECHNOLOGY
At MindGuide we use immersive technologies including next generation virtual reality and augmented reality to reduce anxiety, treat phobias and increase stress resilience.
The technology is rigorously tested in scientific studies and clinical trials at the University of Basel.
PROJECTS
Reduce specific phobias, such as fear of heights or fear of animals
To be published soon
Reduce social fears, such as fear of public speaking
To be published soon
Increase stress resilience and well-being
Development on request
MindGuide offers tailored applications for hospitals and companies
ABOUT
MindGuide is a Division of GeneGuide, a spin-off company of the University of Basel, founded 2013, and directed by the two founders
Dominique de Quervain, M.D., is a full Professor at the Faculty of Medicine & Faculty of Psychology and Director of the Division of Cognitive Neuroscience, University of Basel, Switzerland.
Andreas Papassotiropoulos, M.D., is a full Professor at the Faculty of Medicine & Faculty of Psychology and Director of the Division of Molecular Neuroscience, University of Basel, Switzerland.
Andreas Papassotiropoulos and Dominique de Quervain share more than 18 years of scientific collaboration. They have published numerous milestone publications in leading journals, such as Nature, Science, Cell, Nature Neuroscience, Nature Communications, Nature Human Behaviour, Neuron, and PNAS on human cognitive and emotional functions, including clinical trials. Click here for the full publication list.
GeneGuide AG
MindGuide
Birmannsgasse 8
4055 Basel
Switzerland